Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07672106

Assessment of Reintubation Risk Using Multiple Parameters in Postoperative Intensive Care Unit Patients

This prospective, non-interventional observational study will evaluate the risk of reintubation in adult postoperative patients admitted to the intensive care unit after major surgery. Reintubation after extubation is an important clinical problem because it may increase complications, prolong mechanical ventilation, and extend intensive care and hospital stay.

The study will include adult patients who are extubated in the operating room and admitted to the intensive care unit with spontaneous breathing. Within the first hours after ICU admission, bedside ultrasound measurements of diaphragm thickness, parasternal intercostal muscle thickness, and lung ultrasound score will be performed. The ROX index will also be calculated using oxygen saturation, inspired oxygen concentration, and respiratory rate. Perioperative fluid balance will be recorded from anesthesia and patient files.

Patients will be followed for 48 to 72 hours after ICU admission to determine whether reintubation is required. The study aims to assess whether respiratory muscle ultrasound findings, lung ultrasound score, ROX index, and perioperative fluid balance can help predict reintubation risk in postoperative ICU patients. No additional treatment or intervention will be applied as part of the study, and all clinical decisions will be made by the responsible intensive care team according to routine clinical practice.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Prof. Dr. Cemil Taşçıoğlu Şehir Hastanesi

Istanbul, Şişli, 34360, Turkey (Türkiye)

Location status: Recruiting

Location contact

Zekeriya Ervatan

CONTACT

[email protected]

+9005055983248

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients aged 18 years and older

Patients requiring postoperative intensive care follow-up after major surgery, including abdominal, vascular, orthopedic, or ear, nose, throat, head and neck surgery

Patients extubated in the operating room and admitted to the intensive care unit with spontaneous breathing

Patients without any clinical condition preventing the planned measurements within the first 0-2 hours after ICU admission (T0 and T1)

Patients for whom written informed consent can be obtained from the patient or legally authorized representative

Patients admitted to the intensive care unit within the specified study period after ethics committee approval and enrolled consecutively

Exclusion criteria

Patients younger than 18 years of age

Patients who leave the operating room intubated or are admitted to the intensive care unit while intubated

Patients with a tracheostomy

Patients with a history of diaphragmatic paralysis

Patients with a significant neuromuscular disease, such as ALS, myasthenia gravis, or similar conditions

Patients with conditions that significantly prevent ultrasound measurements, including marked subcutaneous emphysema, large dressings or bandages covering the measurement area, inability to access the measurement site due to drains or the surgical field, or inability to obtain technically adequate images

Patients in whom the planned measurements cannot be performed due to clinical instability requiring emergency intubation immediately after ICU admission

Patients from whom informed consent cannot be obtained, or patients or legally authorized representatives who refuse participation

Treatment and study plan

Primary outcomes

  1. Reintubation Within 72 Hours After Intensive Care Unit Admission

    Time frame: From intensive care unit admission to 72 hours after admission

    The primary outcome is the development of reintubation within the first 72 hours after admission to the intensive care unit. Reintubation is defined as the need for endotracheal intubation after initial extubation in the operating room and admission to the intensive care unit with spontaneous breathing. The decision for reintubation will be made by the responsible intensive care team according to routine clinical criteria and independently of the study protocol. The outcome will be recorded as yes or no.

Secondary outcomes

  1. Diaphragm Thickness at Intensive Care Unit Admission

    Time frame: Within 0-30 minutes after intensive care unit admission

    Diaphragm thickness will be measured by bedside ultrasonography within the first 0-30 minutes after intensive care unit admission. Measurements will be obtained from the same anatomical site with at least three repeated measurements, and the mean value will be used for analysis. Diaphragm thickness values will be evaluated for their association with reintubation within 72 hours.

  2. Parasternal Intercostal Muscle Thickness at Intensive Care Unit Admission

    Time frame: Within 0-30 minutes after intensive care unit admission

    Parasternal intercostal muscle thickness will be measured by bedside ultrasonography within the first 0-30 minutes after intensive care unit admission. At least three repeated measurements will be obtained, and the mean value will be used for analysis. Parasternal intercostal muscle thickness values will be evaluated for their association with reintubation within 72 hours.

  3. Lung Ultrasound Score at Intensive Care Unit Admission

    Time frame: Within 0-30 minutes after intensive care unit admission

    Lung ultrasound score will be assessed using a 12-region lung ultrasound examination. Each region will be scored from 0 to 3, and the total score will range from 0 to 36. Higher scores indicate greater loss of lung aeration. Lung ultrasound score will be evaluated for its association with reintubation within 72 hours.

Sponsors and collaborators

Lead sponsor

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 26, 2026
Registry last updated
Jun 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.